Bristol-Myers Squibb BMYB34 Income Statements

Conto economico

Quarter End	Dic 2022	Mar 2023	Giu 2023	Set 2023	Dic 2023	Mar 2024	Giu 2024	Set 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	11,41B	11,34B	11,23B	10,97B	11,48B	11,87B	12,2B	11,89B
Reddito operativo	1,19B	2,39B	1,19B	1,45B	1,64B	-11,67B	1,33B	1,73B
Reddito ante imposte	1,86B	2,77B	1,86B	2,14B	1,67B	-11,52B	1,29B	1,68B
Reddito netto	2,02B	2,26B	2,07B	1,93B	1,76B	-11,91B	1,68B	1,21B
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	0	0	0	0	0	0	0	0
UTILE OPERATIVO	1,21B	2,96B	2,05B	2,08B	1,84B	-11,27B	1,72B	2,09B
EBITDA	3,69B	4,82B	3,62B	3,89B	4,24B	-9,14B	3,93B	4,37B

Fine anno 31 Dicembre 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	19,43B	20,78B	22,56B	26,15B	42,52B	46,39B	46,16B	45,01B
Reddito operativo	4,69B	3,83B	4,43B	5,8B	3,12B	7,87B	7,24B	6,91B
Reddito ante imposte	5,92B	5,13B	5,97B	4,98B	-6,87B	8,1B	7,71B	8,44B
Reddito netto	4,46B	1,01B	4,92B	3,44B	-9,02B	6,99B	6,33B	8,03B
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	2.659	0.617	3.014	1.538	-4.045	3.14	2.176	3.93
UTILE OPERATIVO	6,02B	5,32B	5,98B	5,17B	-7,33B	9,13B	9,03B	9,15B
EBITDA	5,33B	4,86B	5,28B	7,69B	14,73B	18,45B	17,42B	16,8B